First Published Online November 25, 2009 The Oncologist, Vol. 14, No. 12, 1205-1208, December 2009; doi:10.1634/theoncologist.2009-0184 © 2009 AlphaMed Press
Plasmacytoid Dendritic Cell Leukemia: A Rapidly Evolving Disease Presenting with Skin Lesions Sensitive to Radiotherapy plus HyperthermiaaSection of Hematology, Department of Clinical and Experimental Medicine, bDepartment of Pathology, and dSection of Dermatology and Venereology, Department of Biomedical and Surgical Sciences, University of Verona, Verona, Italy; cDepartment of Radiotherapy, University Hospital of Verona, Verona, Italy Key Words. Plasmacytoid dendritic cell leukemia • Therapy • Radiotherapy plus hyperthermia Correspondence: Cristina Tecchio, M.D., Ph.D., Section of Hematology, Department of Clinical and Experimental Medicine, Policlinico G.B. Rossi, Piazzale L.A. Scuro, University of Verona, 37134 Verona, Italy.Telephone: 011-39-45-8124420;Fax: 011-39-45-501807;e-mail: cristina.tecchio{at}univr.it Received August 16, 2009; accepted for publication October 24, 2009; first published online in THE ONCOLOGIST Express on November 25, 2009.
Disclosures: Cristina Tecchio: None; Chiara Colato: None; Massimiliano Bonifacio: None; Mauro Krampera: None; Sergio Maluta: None; Giovanni Pizzolo: None; Giampiero Girolomoni: None.
Plasmacytoid dendritic cell leukemia (pDCL) is a rapidly evolving disease, which frequently presents with skin lesions, particularly nodules and plaques with a typical reddish-brown or brown color. Treatment of pDCL is based on multiagent chemotherapy followed by allogeneic hematopoietic stem cell transplant, but skin lesions may be refractory to therapy. Here, we report on a 61-year-old patient affected by pDCL who first presented with multiple cutaneous nodules and plaques on the trunk. Lesions showed an excellent response to radiotherapy plus hyperthermia. Although this treatment did not avoid the systemic evolution of disease, it resolved skin lesions and prevented their relapse, thus representing a therapeutic option to be used in combination with chemotherapy regimens. The case presentation is followed by a general discussion with an emphasis on the diagnosis and treatment of this rare malignancy.
Copyright © 2009 by AlphaMed Press. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||